Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, B Cell

Clinical trial condition

Lymphoma, B Cell

Explore clinical trials studying Lymphoma, B Cell. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B Cell trial results

Not Yet Recruiting

A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

NCT07735533

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma

NCT02679196

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

NCT00210314

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland

View Trial Details

Completed

Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

NCT00210379

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland

View Trial Details